Seven peptides are being reviewed by an FDA panel. Here’s what to know.
- Posted on July 23, 2026
- By Washington Post
- 0 Views
- 1 min read
In brief
Generating AI summary…
Seven peptides are being reviewed by an FDA panel. Here’s what to know.
The peptides being evaluated have been proposed to treat conditions including insomnia, ulcerative colitis, migraines and obesity.
